151 related articles for article (PubMed ID: 2488375)
1. Recombinant human erythropoietin in patients on peritoneal dialysis.
Bargman J
Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
[No Abstract] [Full Text] [Related]
2. Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
Nissenson AR
Perit Dial Int; 1992; 12(4):350-2. PubMed ID: 1420491
[No Abstract] [Full Text] [Related]
3. Subcutaneous recombinant human erythropoietin treatment of children undergoing peritoneal dialysis.
Fine RN
Contrib Nephrol; 1991; 89():186-9. PubMed ID: 1893725
[No Abstract] [Full Text] [Related]
4. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
Eisele G; Bailie GR; Clement C; Wong E
Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
Ongkingco JR; Ruley EJ; Turner ME; Fragale MR
Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin and peritoneal dialysis.
Digenis GE; Yatzidis H
Int J Artif Organs; 1990 Jun; 13(6):344-6. PubMed ID: 2199378
[No Abstract] [Full Text] [Related]
8. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
[TBL] [Abstract][Full Text] [Related]
9. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.
Bárány P; Clyne N; Hylander B; Johansson AC; Simonsen O; Larsson R; Frisenette-Fich C; Svensson B; Helmers C
Perit Dial Int; 1995; 15(1):54-60. PubMed ID: 7734561
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal administration of recombinant human erythropoietin.
Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
[TBL] [Abstract][Full Text] [Related]
12. Self-administered daily subcutaneous recombinant human erythropoietin: an open randomised dose-finding study in ESRD patients receiving peritoneal dialysis.
Slingeneyer A; Faller B; Laroche B; Ehmer B; Mion C
Contrib Nephrol; 1991; 88():159-68. PubMed ID: 2040178
[No Abstract] [Full Text] [Related]
13. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
Miranda B; Selgas R; Riñon C; Fernandez-Zamorano A; Borrego F; Ortuño F; Lopez-Revuelta K; Torre A; Sanchez Sicilia L
Adv Perit Dial; 1990; 6():296-301. PubMed ID: 1982831
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
Icardi A; Paoletti E; Molinelli G
Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
[TBL] [Abstract][Full Text] [Related]
15. Treatment of renal anemia with recombinant human erythropoietin.
Schaefer RM; Hörl WH; Massry SG
Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Chung WW; Leung CB; Chan K; Lai KN
Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
Bargman JM; Jones JE; Petro JM
Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients.
Boran M; Dalva I; Yazicioğlu A; Cetin S
Nephron; 1993; 63(1):113-4. PubMed ID: 8446239
[No Abstract] [Full Text] [Related]
19. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
